Plateforme PRETA P3I
Grenoble, 38043, France
NCT Number: NCT06132724
The goal of this observational study is to learn about physiological transitions around the limit of moderate exercise intensity on cardiac, respiratory and motor modalities, in healthy population.
The main questions it aims to answer is:
* is it possible to define criteria on cardiac, respiratory and motor modalities to identify transitions? * are those transitions visible on embedded and non-intrusive monitoring equipment? * are those identified transitions somehow connected to first ventilatory threshold (VT1)?
Participants will do a sub-maximal effort test on cycloergometer calibrated to make them cross their first ventilatory threshold.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Observational
Grenoble, 38043, France
Cycling is a commonly prescribed activity when it comes to physical activities for rehabilitation. Because it is soft and progressive effort, cycling suits well for patients with chronic conditions (diabete, cancer, fibromyalgia, ...) For safety and effectiveness of the activity, it is necessary to prescribe activity at a regular and moderate intensity. This can be achieved by personalizing intensities to match specifically the patient health condition in order to build an efficient and progressive rehabilitation program.
Physical activity prescription rely on four pillars: frequency, duration, volume and intensity. While first three pillars are quite easy to regulate,effort intensity is harder to handle on training planning. It is harder to measure, and defining personalized guideline for practice is more complex.
It is known that first ventilatory threshold (VT1) is a individualized marker representing the higher limit of moderate intensity effort zone. It makes it an interesting tool for the prescription of intensity for retraining purposes: it guaranties a safe practice, intense enough to make beneficial physiological adaptations for the patient.
In this retraining context and with this study, we aim to identify markers of this transition on cardiac, respiratory and motor modalities, with embedded and non intrusive equipment, during a sub-maximal effort test in laboratory.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Synchronized signals from cardiac, respiratory and movements non invasive measurements.
One acquisition is 20 minutes long, and each subject participate to two sessions, separated by 1 to 15 days.
Time frame: 20 minutes
Synchronized signals from embedded and non-intrusive connected devices for cardiorespiratory and motricity measurements and equivalent laboratory measurements during cycling on a cyclo-ergometer
Time frame: 15 minutes
Questionnaire at the end of each session to assess the comfort / discomfort wearing the equipment used during the test
Time frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the respiratory criteria
Time frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the cardiac criteria
Time frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the motricity criteria
Time frame: 6 months
Correlation with the measurement of ventilatory threshold 1 (VT1)
University Hospital, Grenoble
Other
Observation et Mise en Relation Des Transitions Cardio-respiratoires et Motrices à la frontière de l'Exercice modéré
Acronym: CAREMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06967714
Behavior, Healthy
Brussels, Belgium
View Trial DetailsNCT07276464
Behavior, Colitis
Bruz, Britanny, France
View Trial DetailsNCT03886558
Aging, Behavior
Pontevedra, Spain
View Trial DetailsNCT03876314
Alzheimer Disease, Behavior
Greensboro, North Carolina, United States
View Trial Details